About Ian Howes
Form D filings for Automera US in 2023 list Ian Howes as executive officer and promoter.
Form D filings also name Ian Howes as an executive officer at KayoThera.
Ian Howes reports to the SEC as a director, officer or major shareholder of 1 public company: ALSP Orchid Acquisition Corp I (ALOR).
Ian Howes first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Ian Howes in the role, so the role may have started earlier or lasted longer.
Automera US Inc.
Executive officer and promoter
2023 · Seattle, WA
Develops potential cancer treatments using drug discovery tools and targeted protein degradation.
AI
ALSP Orchid Acquisition Corp I
Chief Financial Officer and director
2021 – 2022 · Public company (ALOR)
Key Colleagues at Startups
The people Ian Howes works with at each company, as listed on that company's latest Form D.
Automera US Inc. · Form D, Sep 27, 2023
BW
Benjamin Zian-Loong Wang
Director
KM
Kendall Mohler
Executive officer
TL
Thong Le
Chief Executive Officer and director
SR
Suzanne Rettenmier
Executive officer
YC
Yu-Chieh Alice Chen
Director
WH
Wen Qi Ho
Director
KayoThera, Inc. · Form D/A, Jul 13, 2023
TL
Thong Le
Chief Executive Officer and director
ME
Mark Esposito
Executive officer and director
KM
Kendall Mohler
Executive officer and director